Home/Filings/4/0000950170-25-050103
4//SEC Filing

Wapnick Pamela 4

Accession 0000950170-25-050103

CIK 0001785279other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 11:58 AM ET

Size

7.2 KB

Accession

0000950170-25-050103

Insider Transaction Report

Form 4
Period: 2025-04-01
Wapnick Pamela
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2025-04-01+14,00073,684 total
  • Award

    Stock Option (Right to Buy)

    2025-04-01+84,00084,000 total
    Exercise: $1.32Exp: 2035-03-31Common Stock (84,000 underlying)
Footnotes (2)
  • [F1]These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2026, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
  • [F2]25% of the shares subject to this option shall vest and become exercisable on April 1, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Documents

1 file

Issuer

Metagenomi, Inc.

CIK 0001785279

Entity typeother

Related Parties

1
  • filerCIK 0001995657

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 11:58 AM ET
Size
7.2 KB